Patents by Inventor Ann Marie Wright

Ann Marie Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230380494
    Abstract: A device that enables a user to use a dry vaporizable substance instead of liquid vaporizable substance with a liquid-based tank-style vaporizer. The present invention embodies a modification of existing components of the tank-style vaporizer thereby allowing dry vaporizable substance to be placed for use with the modified vape tank. This vape tank modification embodied in an inventive method that does not require affirmative installation and is immediately ready for use once the modification is complete.
    Type: Application
    Filed: May 22, 2023
    Publication date: November 30, 2023
    Inventor: Ann Marie Wright
  • Patent number: 11378570
    Abstract: A cytotoxicity method for medical devices that has equivalent sensitivity, and greater efficiency compared to the colony formation assay (CFA) direct contact method is developed. The quantitative, direct contact cytotoxicity test method uses Mouse lymphoma TK or human lymphoblastoid TK6 suspension cells for medical device safety assessment. The advantages of using the suspension cell assay over adherent V79-4 cells is that this approach is quantitative, automated, not susceptible to potential mechanical damage imparted by the overlying test materials, and avoids issues related to non-adherence of cells to the test material which might impact the interpretation of test results.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: July 5, 2022
    Assignee: Alcon Inc.
    Inventors: Xuemei Liu, Fan Zhang, Denise P. Rodeheaver, Ann Marie Wright, Charlon Tolliver, Jamie Michaelis Walker, Robert Edward Rose, Stephen Paul Shannon, Jeffrey Charles White
  • Publication number: 20180348205
    Abstract: A cytotoxicity method for medical devices that has equivalent sensitivity, and greater efficiency compared to the colony formation assay (CFA) direct contact method is developed. The quantitative, direct contact cytotoxicity test method uses Mouse lymphoma TK or human lymphoblastoid TK6 suspension cells for medical device safety assessment. The advantages of using the suspension cell assay over adherent V79-4 cells is that this approach is quantitative, automated, not susceptible to potential mechanical damage imparted by the overlying test materials, and avoids issues related to non-adherence of cells to the test material which might impact the interpretation of test results.
    Type: Application
    Filed: May 24, 2018
    Publication date: December 6, 2018
    Inventors: Xuemei Liu, Fan Zhang, Denise P. Rodeheaver, Ann Marie Wright, Charion Tolliver, Jamie Michaelis Walker, Robert Edward Rose, Stephen Paul Shannon, Jeffrey Charles White
  • Patent number: 6220253
    Abstract: A dental implement storage assembly for holding primary dental care implements and providing storage compartments, a mirror, and a cover usable as a rinsing cup. The dental implement storage assembly includes a housing having a plurality of receptacles for holding dental implements, a plurality of compartments having doors positioned around the outside of the housing, and a cover removable from the housing for use as a cup. A mirror is positioned in one of the compartments.
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: April 24, 2001
    Inventor: Ann Marie Wright